LeTech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

LeTech şirketinin toplam hissedar öz sermayesi ¥5.2B ve toplam borcu ¥16.2B olup, bu da borç-öz sermaye oranını 310.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥24.5B ve ¥19.3B dir. LeTech 'in FAVÖK'ü ¥1.5B faiz karşılama oranı 4.5 dur. Şirketin ¥2.6B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

310.7%

Borç/özkaynak oranı

JP¥16.21b

Borç

Faiz karşılama oranı	4.5x
Nakit	JP¥2.57b
Eşitlik	JP¥5.22b
Toplam yükümlülükler	JP¥19.31b
Toplam varlıklar	JP¥24.53b

Son finansal sağlık güncellemeleri

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

Sep 17

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

Mar 19

Recent updates

LeTech Corporation's (TSE:3497) Price Is Right But Growth Is Lacking After Shares Rocket 29%

Sep 19

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

Sep 17

LeTech Corporation's (TSE:3497) 34% Dip In Price Shows Sentiment Is Matching Revenues

Aug 03

With EPS Growth And More, LeTech (TSE:3497) Makes An Interesting Case

Jul 30

LeTech Corporation's (TSE:3497) Price Is Out Of Tune With Revenues

Jun 10

We Think You Should Be Aware Of Some Concerning Factors In LeTech's (TSE:3497) Earnings

Mar 27

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

Mar 19

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 3497 'nin kısa vadeli varlıkları ( ¥23.1B ) kısa vadeli yükümlülüklerini ( ¥11.9B ) aşıyor.

Uzun Vadeli Yükümlülükler: 3497 şirketinin kısa vadeli varlıkları ( ¥23.1B ) uzun vadeli yükümlülüklerini ( ¥7.4B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 3497 'nin net borç/öz sermaye oranı ( 261.4% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 3497 'nin borç/öz sermaye oranı son 5 yılda 1165.1% seviyesinden 310.7% seviyesine düştü.

Borç Kapsamı: 3497 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 3497 'in borcuna ilişkin faiz ödemeleri EBIT ( 4.5 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

LeTech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

Recent updates

LeTech Corporation's (TSE:3497) Price Is Right But Growth Is Lacking After Shares Rocket 29%

Full year 2024 earnings released: EPS: JP¥226 (vs JP¥249 in FY 2023)

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

LeTech Corporation, Annual General Meeting, Oct 29, 2024

LeTech Corporation's (TSE:3497) 34% Dip In Price Shows Sentiment Is Matching Revenues

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 20%

With EPS Growth And More, LeTech (TSE:3497) Makes An Interesting Case

LeTech Corporation to Report Fiscal Year 2024 Results on Sep 17, 2024

Upcoming dividend of JP¥41.00 per share

Third quarter 2024 earnings released: EPS: JP¥8.93 (vs JP¥53.52 in 3Q 2023)

LeTech Corporation's (TSE:3497) Price Is Out Of Tune With Revenues

LeTech Corporation to Report Q3, 2024 Results on Jun 14, 2024

We Think You Should Be Aware Of Some Concerning Factors In LeTech's (TSE:3497) Earnings

Dividend increased to JP¥41.00

LeTech (TSE:3497) Has A Somewhat Strained Balance Sheet

LeTech Corporation to Report Q2, 2024 Results on Mar 18, 2024

First quarter 2024 earnings released: EPS: JP¥18.33 (vs JP¥17.99 loss in 1Q 2023)

Full year 2023 earnings released: EPS: JP¥249 (vs JP¥1,470 loss in FY 2022)

LeTech Corporation to Report Q1, 2024 Results on Dec 15, 2023

Letech Corporation Provides Earnings Guidance for the Fiscal Year Ending July 31, 2024

Investor sentiment deteriorates as stock falls 23%

Full year 2023 earnings released: EPS: JP¥261 (vs JP¥1,470 loss in FY 2022)

LeTech Corporation, Annual General Meeting, Oct 27, 2023

LeTech Corporation to Report Fiscal Year 2023 Results on Sep 14, 2023

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: JP¥53.52 (vs JP¥34.30 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: JP¥112 (vs JP¥1,112 loss in 2Q 2022)

LeTech Corporation to Report Q2, 2023 Results on Mar 17, 2023

First quarter 2023 earnings released: JP¥17.99 loss per share (vs JP¥113 loss in 1Q 2022)

Less than half of directors are independent

Full year 2022 earnings released: JP¥1,470 loss per share (vs JP¥196 profit in FY 2021)

LeTech Corporation to Report Q1, 2023 Results on Dec 15, 2022

Full year 2022 earnings released: JP¥1,470 loss per share (vs JP¥196 profit in FY 2021)

LeTech Corporation, Annual General Meeting, Oct 28, 2022

LeTech Corporation to Report Fiscal Year 2022 Results on Sep 14, 2022

LeTech Corporation announced that it expects to receive ¥3.000000512 billion in funding

Third quarter 2022 earnings released: JP¥34.30 loss per share (vs JP¥59.30 loss in 3Q 2021)

Less than half of directors are independent

LeTech Corporation Provides Earnings Guidance for the Fiscal Year Ending July 31, 2022

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥196 (vs JP¥32.91 in FY 2020)

Full year 2021 earnings released: EPS JP¥196 (vs JP¥32.91 in FY 2020)

Investor sentiment deteriorated over the past week

NichiiGakkan Co., Ltd. signed an agreement to acquire Nishinihon Healthcare Co., Ltd. from LeTech Corporation (TSE:3497).

LeTech Corporation Provides Earnings Guidance for the Fiscal Year Ending July 31, 2021

Second quarter 2021 earnings released: EPS JP¥82.90 (vs JP¥21.75 in 2Q 2020)

New 90-day high: JP¥1,018

Legal Corporation to Report Q2, 2021 Results on Mar 16, 2021

First quarter 2021 earnings released: EPS JP¥11.16

Legal Corporation to Report Q1, 2021 Results on Dec 15, 2020

Legal Corporation to Report Fiscal Year 2020 Results on Sep 14, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin